Work

Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities

Year: 2019

Type: review

Source: Trends in Immunology

DOI: 10.1016/j.it.2019.04.002

Authors: Kristen E. Pauken, Michael Dougan, Noel R. Rose, Andrew H. Lichtman, Arlene H. Sharpe

Institutions: Brigham and Women's Hospital, Harvard University, Massachusetts General Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: AstraZeneca, Regeneron Pharmaceuticals, National Institutes of Health, Genentech, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1690409392, G2331928182, G4084372155, G4560519890, G4678552911, T cell costimulation and regulation in myocarditis, T Cell Costimulatory Pathways: Functions and Interactions, G9000304050, G9000341336, Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital

OpenAlex ID: W2943668434

FWCI: 3.921

Cites: 97

Cited by: 279

Related to: 10